Well, the marketâs are closed â but Iâm here doing research on [my #1 biotech catalyst play.]( I want to make sure Iâve done all the due diligence I can. Hereâs the rundown: - Itâs trading under $0.50 as we speak and has upside all the way to $4. - There are multiple catalysts on the table in the coming days and weeks. - The stock is considered a low float. In other words, thereâs not a whole lot of supply. - Insiders made large purchases in 2021, and theyâre underwater.Thereâs a chance they may purchase shares ahead of the catalyst event, which can send the stock moving! - The company is working on breakthrough therapies for autoimmune and inflammatory diseases, and itâs becoming a pivotal year for the stock. - The pattern Iâm seeing is what I call the âconsolidation to breakoutâ. This stock looks as if it can start to run up into its catalyst events. [Iâm going to reveal my trade plan and what Iâm seeing in the stock LIVE on Monday at 3 PM ETâ¦](BEFORE I buy a single share. Iâm doing this to teach you about some of the most electrifying opportunities in the market. The only way you can watch me release this trade LIVE, and [get the alert via the RagingBull app is by joining Biotech Breakouts.]( This is by far the best opportunity for you to learn and put your skills to the test, if youâre comfortable⦠[And since I want to make this a no-brainer, Iâve slashed the price to the bone!]( [Thereâs not a lot of time left to take action.]( Jeff Williams RagingBull, LLC
62 Calef Hwy. #233, Lee, NH 03861 [Manage your email subscriptions.]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.